Please login to the form below
COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
Fallout from pandemic continues to affect business in myriad ways
UK contributes £210m towards COVID-19 vaccine efforts
Prime Minister Boris Johnson also tests positive for coronavirus
Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
First patient is likely to be treated later in the year due to pandemic
In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
Monthly meeting held remotely for the first time due to COVID-19 pandemic
BMS suspends new clinical trials as COVID-19 cases rise in US
Existing sites can continue to recruit new subjects
Novartis forms coronavirus alliance with life sciences companies
Partnership will accelerate research with aid of Gates Foundation
Immutep slumps on latest efti data in breast cancer
Drug was unable to improve progression-free survival compared to placebo
UK-Senegal partners plan to validate ten-minute COVID-19 diagnostic
Rapid test kit will aim to curb virus' spread across Africa
Merck gets first okay for MET inhibitor tepotinib in Japan
First worldwide approval for MET inhibitor
Q&A: Mike Dixon
PME interviews the CEO of the Healthcare Communications Association (HCA)
-
Q&A: Stefi RucciPME interviews SAY Communications' joint MD and Director of Healthcare
-
Q&A: Emma SergeantPME interviews president of the DAS Group of Companies in Europe
-
NHS to set up hospital in ExCeL Centre as coronavirus cases growOver half a million people have also volunteered with the health service
-
AstraZeneca forms $2bn gene silencing pact with Silence TxCollaboration focuses on cardiovascular, renal, metabolic and respiratory disease
-
UPDATED: Gilead drops remdesivir’s orphan drug designationDecision comes amid intense public criticism of the regulatory status
-
FDA approves Roche’s Actemra COVID-19 trial Plans to initiate trial in early April
-
FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetesFormally rejects extended use of SGLT2 inhibitor
-
Lilly halts most clinical trials as coronavirus disruption continuesWill continue ongoing trials for patients who are already enrolled
-
AbbVie suspends Kaletra patent rights as COVID-19 drug trials advanceDrug and vaccine trials pick up speed as virus spreads
Latest appointments
-
Dan Russell joins Seven Stones as managing directorJoins the team to help drive global expansion
-
McCann Health France strengthens team with two new hires Melissa Brunet and Christelle David-Basei join the agency
-
Ashfield appoints new global head of quality and complianceInternal candidate Carey Galvin to take on the role
-
NICE looks internally for new chief executive Deputy chief exec Gillian Leng is set to take the helm
-
AstraZeneca taps internal candidate to become UK presidentTom Keith-Roach has worked at the company for 17 years
COVID-19 Updates and Daily News
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Manager
-
£Competitive Salary
-
Account Director – UK Office
-
Excellent salary and benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance
- Novartis forms coronavirus alliance with life sciences companies
- UK biotech Synairgen to begin COVID-19 trial of lead candidate
- Takeda begins development of COVID-19 plasma therapy
- UK, China prep trials of coronavirus vaccine candidates
- Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
- UK contributes £210m towards COVID-19 vaccine efforts
- Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
- In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
- COVID-19 message to clients from OPEN Health CEO, David Rowley
- The march to sustainability
PMHub
Virgo Health
Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...
Latest intelligence
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
- Virtual Research Grants Submission and Approval Program
- Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....
Quick links
Infographics
